Reply on Missing Ligand Model in Stem Cell Transplantation
Author Information
Author(s): Leung W, Handgretinger R, Turner V, Hale G A
Primary Institution: St Jude Children's Research Hospital
Hypothesis
Does the absence of KIR-ligand imply an inhibitory KIR–HLA receptor–ligand mismatch?
Conclusion
The study suggests that misclassification of patients based on KIR-ligand presence can lead to incorrect conclusions about clinical outcomes.
Supporting Evidence
- 2 out of 16 patients would have been misclassified using the analytic approach of Stern et al.
- Previous studies have shown that misclassification can bias results towards null.
- 86% of patients with KIR3DL1 mismatch were alive compared to 22% without.
Takeaway
If some important signals are missing in a medical test, doctors might think patients are doing better or worse than they really are.
Methodology
The study analyzed patient outcomes based on KIR3DL1 mismatch and its effect on survival rates.
Potential Biases
Potential misclassification of patients could bias the results.
Limitations
The findings need to be confirmed in larger studies with appropriate models and designs.
Participant Demographics
Patients undergoing autologous stem cell transplantation.
Statistical Information
P-Value
0.01
Confidence Interval
0.1–2.8
Statistical Significance
p=0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website